Webb K - Search Results

1

Recent advances in pharmacotherapy for dyspnea in COPD.

Raghavan N, Webb K, Amornputtisathaporn N, O'Donnell DE. Raghavan N, et al. Among authors: webb k. Curr Opin Pharmacol. 2011 Jun;11(3):204-10. doi: 10.1016/j.coph.2011.03.002. Epub 2011 Mar 28. Curr Opin Pharmacol. 2011. PMID: 21450522 Review.

2

Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.

O'Donnell DE, Hamilton AL, Webb KA. O'Donnell DE, et al. J Appl Physiol (1985). 2006 Oct;101(4):1025-35. doi: 10.1152/japplphysiol.01470.2005. Epub 2006 May 4. J Appl Physiol (1985). 2006. PMID: 16675610 Free article. Clinical Trial.

3

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.

O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, Gelb AF, Mahler DA, Webb KA. O'Donnell DE, et al. Proc Am Thorac Soc. 2007 May;4(2):145-68. doi: 10.1513/pats.200611-159CC. Proc Am Thorac Soc. 2007. PMID: 17494725 Review.

4

The major limitation to exercise performance in COPD is dynamic hyperinflation.

O'Donnell DE, Webb KA. O'Donnell DE, et al. J Appl Physiol (1985). 2008 Aug;105(2):753-5; discussion 755-7. doi: 10.1152/japplphysiol.90336.2008b. J Appl Physiol (1985). 2008. PMID: 18678624 Free article. No abstract available.

5

Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.

Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Ora J, et al. Am J Respir Crit Care Med. 2009 Nov 15;180(10):964-71. doi: 10.1164/rccm.200904-0530OC. Am J Respir Crit Care Med. 2009. PMID: 19897773

6

Effect of obesity on respiratory mechanics during rest and exercise in COPD.

Ora J, Laveneziana P, Wadell K, Preston M, Webb KA, O'Donnell DE. Ora J, et al. Among authors: webb ka. J Appl Physiol (1985). 2011 Jul;111(1):10-9. doi: 10.1152/japplphysiol.01131.2010. Epub 2011 Feb 24. J Appl Physiol (1985). 2011. PMID: 21350021 Free article.

7

Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms.

Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE. Guenette JA, et al. Respir Physiol Neurobiol. 2011 Aug 15;177(3):218-27. doi: 10.1016/j.resp.2011.04.011. Epub 2011 Apr 16. Respir Physiol Neurobiol. 2011. PMID: 21524719

8

Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise.

O'Donnell DE, Guenette JA, Maltais F, Webb KA. O'Donnell DE, et al. Chest. 2012 Mar;141(3):753-762. doi: 10.1378/chest.11-0787. Epub 2011 Aug 18. Chest. 2012. PMID: 21852298

9

Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints.

Laveneziana P, Webb KA, Ora J, Wadell K, O'Donnell DE. Laveneziana P, et al. Among authors: webb ka. Am J Respir Crit Care Med. 2011 Dec 15;184(12):1367-73. doi: 10.1164/rccm.201106-1128OC. Epub 2011 Sep 1. Am J Respir Crit Care Med. 2011. PMID: 21885624 Clinical Trial.

10

Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.

Guenette JA, Raghavan N, Harris-McAllister V, Preston ME, Webb KA, O'Donnell DE. Guenette JA, et al. Respir Med. 2011 Dec;105(12):1836-45. doi: 10.1016/j.rmed.2011.08.021. Epub 2011 Sep 13. Respir Med. 2011. PMID: 21917440 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,040 results

Search Page

Filters